facial paresis

Trials

76 participants · First posted Aug 18, 2015

Unknown

NCT04074018

Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis

82 participants · First posted Aug 29, 2019

Terminated

NCT01833221

Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty

10 participants · First posted Apr 16, 2013

Drugs

View all 48 →

Small Molecule

Investigational

Col-118

Small Molecule

Approved

Brimonidine(Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza)

Manufacturer: Allergan inc, Allergan +7 more

Conditions: Increased Intra Ocular Pressure (IOP), Ocular Hypertension +1 more

C₁₁H₁₀BrN₅ · Rx

Small Molecule

Approved

Oxymetazoline(Afrin, Dristan 12-hour Nasal Spray, Kovanaze, Nostrilla, Rhofade, Sinex Long-acting, Upneeq, Zicam Sinus Relief)

Manufacturer: Schering plough healthcare products inc, Johnson and johnson group consumer companies

Conditions: Acquired Blepharoptosis, Allergic Rhinitis (AR) +6 more

C₁₆H₂₄N₂O

Organizations

View all 49 →

Facial Concepts, Inc.

United States

MASSACHUSETTS EYE AND EAR INFIRMARY & PHYSICIAN STAFF, INC.

United States

Revance Therapeutics

United States

Trials

Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors

Impacts of Two Rehabilitation Programs on Chronic Peripheral Facial Paresis

Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty

Drugs

Col-118

Brimonidine(Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza)

Oxymetazoline(Afrin, Dristan 12-hour Nasal Spray, Kovanaze, Nostrilla, Rhofade, Sinex Long-acting, Upneeq, Zicam Sinus Relief)

Organizations

Facial Concepts, Inc.

MASSACHUSETTS EYE AND EAR INFIRMARY & PHYSICIAN STAFF, INC.

Revance Therapeutics

News

FDA Warns of Serious Reactions with Kybella for Submental Fat

BOTOX® Cosmetic Receives FDA Approval for Platysma Bands

FDA Approves Botox Cosmetic for Platysma Bands, Expanding Aesthetic Applications